SIPA1 and triple-negative breast carcinoma: This study explored the expression of lncRNA regulated by SIPA1 protein in triple-negative breast cancer cells and studied its biological function, which is of great significance for exploring the potential diagnostic and therapeutic value of lncRNA in breast cancer and promoting the treatment of tumor metastasis in triple-negative breast cancer patients.